Español
Questions About Cancer? 1-800-4-CANCER
  • Email

Clinical Trials Search Results

Initial search results include only NCI-sponsored clinical trials. To search all trials, click the "REFINE SEARCH" button, scroll down to the Trial ID/Sponsor section and select the "All" check box in the Sponsor of Trial section.

View Content for:
Display:
  •          
Help with display options.
Results 1-25 of 63 for your search:
Drug:  temsirolimus
Find trials that include:  Any drugs shown
Trial Status:  Closed
Start Over
        Show
1.

Phase: Phase IV
Type: Natural history/Epidemiology
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: A6181203, DARENCA STUDY 2, NCT01339962

2.

Phase: Phase IV
Type: Natural history/Epidemiology
Status: Enrolling by invitation
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: B1771017, INHIBITOR, NCT01367457

3.

Phase: Phase III
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI, Pharmaceutical / Industry
Protocol IDs: UCLA-0305091, WYETH-C-3066K1-304-WW, NCT00065468

4.

Phase: Phase III
Type: Biomarker/Laboratory analysis, Treatment
Status: Closed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: CR100848, PCI-32765MCL3001, 2012-000601-74, U1111-1135-6930, NCT01646021

5.

Phase: Phase II, Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCI-2009-00676, CDR0000476286, NABTC-05-02, U01CA137443, ABTC-05-02, NCT00335764

6.

Phase: Phase II, Phase I
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: Other
Protocol IDs: 09-0668 / 201105207, NCT00921310

7.

Phase: Phase II, Phase I
Type: Treatment
Status: Completed
Age: 1 and over
Sponsor: Other
Protocol IDs: J0963, NA_00028490, NCT00949325

8.

Phase: Phase II, Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCI-2011-01406, CDR0000659064, 09-117, 8147, U01CA069856, P30CA008748, MSKCC-09117, IRB #09-117, NCT01026623

9.

Phase: Phase II, Phase I
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: Other
Protocol IDs: 09-131, NCT01016769

10.

Phase: Phase II, Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCI-2011-01409, MSKCC-09058, CDR0000663573, 09-058, 8249, U01CA069856, P30CA008748, NCT01051557

11.

Phase: Phase II, Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Unknown
Age: 16 and over
Sponsor: Other
Protocol IDs: WCTU-TOTEM, WCTU-TOTEM, ISRCTN31546330, EUDRACT-2007-007615-82, EU-21014, WCTU-SPON-417-07, CRUK-08/015, NCT01090466

12.

Phase: Phase II, Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Closed
Age: 18 and over
Sponsor: Other
Protocol IDs: CASE7808, NCI-2010-00308, CASE7808-CC527, NCT01083368

13.

Phase: Phase II, Phase I
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: Other
Protocol IDs: HCC022, NCT01251458

14.

Phase: Phase II, Phase I
Type: Supportive care, Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCI-2011-02650, ECOG-E1A10, CDR0000701362, E1A10, U10CA180820, U10CA021115, NCT01381692

15.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: CDR0000331979, UCLA-0306091, WYETH-C-3066A1-132-US, NCT00071968

16.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCI-2012-02567, MDA-2003-0530, N01CM17003, CDR0000347405, NCI-6182, 6182, NCT00075647

17.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCI-2012-01810, N0323, CDR0000355117, NCCTG-N0323, U10CA025224, NCT00079235

18.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCI-2012-01448, NCI-6186, OSU-0347, CDR0000355767, OSU-2003C0090, 0347, 6186, R21CA112894, N01CM62207, NCT00079456

19.

Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: UCCRC-12983A, NCI-6199, 6199, NCT00084474

20.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCI-2012-02589, MDA-2003-0830, N01CM62202, CDR0000367093, 6178, NCI-6178, NCT00084916

21.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCI-2012-02703, CDR0000495399, NCI-7674, UCIRB 14705A, UCCRC-14705A, 14705A, 7674, P30CA014599, NCT00376688

22.

Phase: Phase II
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCI-2009-00598, CDR0000601291, GOG-0229G, U10CA027469, NCT00723255

23.

Phase: Phase II
Type: Treatment
Status: Closed
Age: Not specified
Sponsor: NCI
Protocol IDs: NCI-2009-01085, CDR0000609740, GOG-0248, U10CA027469, U10CA180868, NCT00729586

24.

Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Other
Protocol IDs: BEV-CCI-779-GBM-02, Eudract no.: 2008-003679-40, NCT00800917

25.

Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 to 70
Sponsor: Other
Protocol IDs: 2008-007665-22, NCT00827684
1    
New Search